Literature DB >> 25728647

Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.

Yi Jin1, Mo Chen1, Trevor M Penning1, Walter L Miller2.   

Abstract

Cytochrome P450 oxidoreductase (POR) is a 2-flavin protein that transfers electrons from NADPH via its FAD and FMN moieties to all microsomal cytochrome P450 enzymes, including steroidogenic and drug-metabolizing P450s. Defects in the POR gene can cause POR deficiency (PORD), manifested clinically by disordered steroidogenesis, genital anomalies and skeletal malformations. We examined the POR mutant A287P, which is the most frequent cause of PORD in patients of European ancestry and partially disrupts most P450 activities in vitro. Flavin content analysis showed that A287P is deficient in FAD and FMN binding, although the mutation site is distant from the binding sites of both flavins. Externally added flavin partially restored the cytochrome c reductase activity of A287P, suggesting that flavin therapy may be useful for this frequent form of PORD. Transient kinetic dissection of the reaction of POR with NADPH and the reduction in cytochrome c by POR using stopped-flow techniques revealed defects in individual electron transfer steps mediated by A287P. A287P had impaired ability to accept electrons from NADPH, but was capable of a fast FMNcytochrome c electron donation reaction. Thus the reduced rates of P450 activities with A287P may be due to deficient flavin and impaired electron transfer from NADPH.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728647      PMCID: PMC4692368          DOI: 10.1042/BJ20141410

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase.

Authors:  H G Enoch; P Strittmatter
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

Review 2.  P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia.

Authors:  Christa E Flück; Walter L Miller
Journal:  Curr Opin Pediatr       Date:  2006-08       Impact factor: 2.856

3.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Authors:  Ningwu Huang; Amit V Pandey; Vishal Agrawal; William Reardon; Pablo D Lapunzina; David Mowat; Ethylin Wang Jabs; Guy Van Vliet; Joseph Sack; Christa E Flück; Walter L Miller
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

4.  Evidence for a new physiological role of hepatic NADPH:ferricytochrome (P-450) oxidoreductase. Direct electron input to the microsomal fatty acid chain elongation system.

Authors:  Z Ilan; R Ilan; D L Cinti
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

5.  Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH.

Authors:  D D Oprian; M J Coon
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

6.  Structural features of liver microsomal NADPH-cytochrome P-450 reductase. Hydrophobic domain, hydrophilic domain, and connecting region.

Authors:  S D Black; M J Coon
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

7.  Determination of nitric oxide synthase cofactors: heme, FAD, FMN, and tetrahydrobiopterin.

Authors:  P Klatt; K Schmidt; E R Werner; B Mayer
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

8.  Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.

Authors:  Christopher C Marohnic; Satya P Panda; Pavel Martásek; Bettie Sue Masters
Journal:  J Biol Chem       Date:  2006-09-24       Impact factor: 5.157

9.  Mechanistic studies on the reductive half-reaction of NADPH-cytochrome P450 oxidoreductase.

Authors:  A L Shen; D S Sem; C B Kasper
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

10.  Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase.

Authors:  J L Vermilion; D P Ballou; V Massey; M J Coon
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

View more
  2 in total

1.  Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.

Authors:  Karen M McCammon; Satya P Panda; Chuanwu Xia; Jung-Ja P Kim; Daniela Moutinho; Michel Kranendonk; Richard J Auchus; Eileen M Lafer; Debashis Ghosh; Pavel Martasek; Rekha Kar; Bettie Sue Masters; Linda J Roman
Journal:  J Biol Chem       Date:  2016-08-05       Impact factor: 5.157

Review 2.  Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.

Authors:  Shabbir Ahmed; Zhan Zhou; Jie Zhou; Shu-Qing Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-10-08       Impact factor: 7.691

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.